ID: ALA3219497

Max Phase: Preclinical

Molecular Formula: C5H9N3O2

Molecular Weight: 143.15

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  NC[C@H]1CNC(=O)C(=O)N1

Standard InChI:  InChI=1S/C5H9N3O2/c6-1-3-2-7-4(9)5(10)8-3/h3H,1-2,6H2,(H,7,9)(H,8,10)/t3-/m0/s1

Standard InChI Key:  WHGANRDWMKINNH-VKHMYHEASA-N

Associated Targets(Human)

Glutamate [NMDA] receptor 933 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 143.15Molecular Weight (Monoisotopic): 143.0695AlogP: -2.44#Rotatable Bonds: 1
Polar Surface Area: 84.22Molecular Species: BASEHBA: 3HBD: 3
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.97CX Basic pKa: 8.72CX LogP: -2.34CX LogD: -3.69
Aromatic Rings: 0Heavy Atoms: 10QED Weighted: 0.36Np Likeness Score: 1.00

References

1. Reymond J, van Deursen R, Blum LC, Ruddigkeit L.  (2010)  Chemical space as a source for new drugs,  (1): [10.1039/C0MD00020E]

Source